vs
Kornit Digital Ltd.（KRNT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Kornit Digital Ltd.的1.4倍（$207.3M vs $143.1M），Kornit Digital Ltd.净利率更高（-13.3% vs -62.0%，领先48.7%），Kornit Digital Ltd.自由现金流更多（$8.8M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 0.6%）
Kornit Digital Ltd.是一家以以色列为发源地、联动美国的跨国制造企业，核心产品为高速工业喷墨打印机、颜料墨水及各类化工产品，广泛服务于服装服饰、家居用品、纺织配饰与纺织印花加工领域。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
KRNT vs RARE — 直观对比
营收规模更大
RARE
是对方的1.4倍
$143.1M
净利率更高
KRNT
高出48.7%
-62.0%
自由现金流更多
KRNT
多$109.6M
$-100.8M
两年增速更快
RARE
近两年复合增速
0.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $143.1M | $207.3M |
| 净利润 | $-19.0M | $-128.6M |
| 毛利率 | 42.4% | — |
| 营业利润率 | -25.2% | -54.7% |
| 净利率 | -13.3% | -62.0% |
| 营收同比 | — | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | — | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRNTRARE
| Q4 25 | — | $207.3M | ||
| Q3 25 | $143.1M | $159.9M | ||
| Q2 25 | $92.4M | $166.5M | ||
| Q1 25 | $43.8M | $139.3M | ||
| Q4 24 | — | $164.6M | ||
| Q3 24 | $163.2M | $139.5M | ||
| Q2 24 | $104.0M | $147.0M | ||
| Q1 24 | $47.8M | $108.8M |
净利润KRNTRARE
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $-19.0M | $-180.4M | ||
| Q2 25 | $-18.1M | $-115.0M | ||
| Q1 25 | $-13.2M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $-41.4M | $-133.5M | ||
| Q2 24 | $-33.3M | $-131.6M | ||
| Q1 24 | $-18.9M | $-170.7M |
毛利率KRNTRARE
| Q4 25 | — | — | ||
| Q3 25 | 42.4% | — | ||
| Q2 25 | 39.4% | — | ||
| Q1 25 | 32.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 32.1% | — | ||
| Q2 24 | 30.6% | — | ||
| Q1 24 | 27.4% | — |
营业利润率KRNTRARE
| Q4 25 | — | -54.7% | ||
| Q3 25 | -25.2% | -106.9% | ||
| Q2 25 | -31.4% | -64.8% | ||
| Q1 25 | -41.8% | -102.6% | ||
| Q4 24 | — | -74.3% | ||
| Q3 24 | -36.6% | -94.6% | ||
| Q2 24 | -43.3% | -79.1% | ||
| Q1 24 | -50.5% | -151.9% |
净利率KRNTRARE
| Q4 25 | — | -62.0% | ||
| Q3 25 | -13.3% | -112.8% | ||
| Q2 25 | -19.6% | -69.0% | ||
| Q1 25 | -30.2% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | -25.4% | -95.7% | ||
| Q2 24 | -32.0% | -89.5% | ||
| Q1 24 | -39.6% | -156.8% |
每股收益（稀释后）KRNTRARE
| Q4 25 | — | $-1.28 | ||
| Q3 25 | — | $-1.81 | ||
| Q2 25 | — | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | — | $-1.34 | ||
| Q3 24 | — | $-1.40 | ||
| Q2 24 | — | $-1.52 | ||
| Q1 24 | — | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $35.0M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $-80.0M |
| 总资产 | $787.5M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KRNTRARE
| Q4 25 | — | $421.0M | ||
| Q3 25 | $35.0M | $202.5M | ||
| Q2 25 | $35.0M | $176.3M | ||
| Q1 25 | $35.0M | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | $39.6M | $150.6M | ||
| Q2 24 | $39.6M | $480.7M | ||
| Q1 24 | $39.6M | $112.3M |
股东权益KRNTRARE
| Q4 25 | — | $-80.0M | ||
| Q3 25 | — | $9.2M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | — | $144.2M | ||
| Q4 24 | — | $255.0M | ||
| Q3 24 | — | $346.8M | ||
| Q2 24 | — | $432.4M | ||
| Q1 24 | — | $140.3M |
总资产KRNTRARE
| Q4 25 | — | $1.5B | ||
| Q3 25 | $787.5M | $1.2B | ||
| Q2 25 | $787.5M | $1.3B | ||
| Q1 25 | $787.5M | $1.3B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $865.6M | $1.5B | ||
| Q2 24 | $865.6M | $1.6B | ||
| Q1 24 | $865.6M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $8.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | 6.2% | -48.6% |
| 资本支出强度资本支出/营收 | 9.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流KRNTRARE
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $22.1M | $-91.4M | ||
| Q2 25 | $8.5M | $-108.3M | ||
| Q1 25 | $4.0M | $-166.5M | ||
| Q4 24 | — | $-79.3M | ||
| Q3 24 | — | $-67.0M | ||
| Q2 24 | — | $-77.0M | ||
| Q1 24 | — | $-190.7M |
自由现金流KRNTRARE
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $8.8M | $-92.7M | ||
| Q2 25 | $5.8M | $-110.7M | ||
| Q1 25 | $2.7M | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
自由现金流率KRNTRARE
| Q4 25 | — | -48.6% | ||
| Q3 25 | 6.2% | -58.0% | ||
| Q2 25 | 6.3% | -66.5% | ||
| Q1 25 | 6.3% | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
资本支出强度KRNTRARE
| Q4 25 | — | 0.5% | ||
| Q3 25 | 9.2% | 0.8% | ||
| Q2 25 | 2.9% | 1.5% | ||
| Q1 25 | 2.9% | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRNT
| Products | $100.4M | 70% |
| Services | $42.8M | 30% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
